Christopher D. Willey

3.5k total citations
118 papers, 2.5k citations indexed

About

Christopher D. Willey is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher D. Willey has authored 118 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 34 papers in Oncology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher D. Willey's work include Glioma Diagnosis and Treatment (27 papers), Brain Metastases and Treatment (12 papers) and Head and Neck Cancer Studies (8 papers). Christopher D. Willey is often cited by papers focused on Glioma Diagnosis and Treatment (27 papers), Brain Metastases and Treatment (12 papers) and Head and Neck Cancer Studies (8 papers). Christopher D. Willey collaborates with scholars based in United States, Japan and Egypt. Christopher D. Willey's co-authors include Joshua C. Anderson, G. Yancey Gillespie, Dhandapani Kuppuswamy, James A. Bonner, Martin Laser, Eddy S. Yang, John B. Fiveash, Kwang Woon Kim, Hoa Q. Trummell and Ling Geng and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Christopher D. Willey

114 papers receiving 2.5k citations

Peers

Countries citing papers authored by Christopher D. Willey

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Willey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Willey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Willey more than expected).

Fields of papers citing papers by Christopher D. Willey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Willey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Willey. The network helps show where Christopher D. Willey may publish in the future.

Co-authorship network of co-authors of Christopher D. Willey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Willey. A scholar is included among the top collaborators of Christopher D. Willey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Willey. Christopher D. Willey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity 2025 ·Nature Communications ·(unknown), (unknown), Sara A. Murphy, Joshua C. Anderson, Vasanta Putluri, Abu Hena Mostafa Kamal, Jun Hyoung Park, Tae Jin Lee, Alexander Ling, Benny Abraham Kaipparettu, Ashok Sharma, Nagireddy Putluri, Pamela L. Wenzel, Christopher D. Willey, E. Antonio Chiocca, James M. Markert, Balveen Kaur	3
2	MODL-30. UTILIZING SERUM-FREE CO-CULTURE MODELS FOR IN-VITRO MODELING OF TUMOR-ASSOCIATED MACROPHAGES IN GLIOBLASTOMA 2023 ·Neuro-Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Joshua C. Anderson, Patricia H. Hicks, Christopher D. Willey	1
3	An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases 2022 ·JCI Insight ·(unknown), Joshua C. Anderson, Zongliang Yue, Thanh Nguyen, (unknown), Catherine P. Langford, Jelai Wang, James Rowland, Chuan Xing, Fady M. Mikhail, Xiangqin Cui, (unknown), Ryan Bash, Kevin J. Lee, Eddy S. Yang, Anita B. Hjelmeland, C. Ryan Miller, Jake Y. Chen, G. Yancey Gillespie, Christopher D. Willey	12
4	N-cadherin upregulation mediates adaptive radioresistance in glioblastoma 2021 ·Journal of Clinical Investigation ·Satoru Osuka, Dan Zhu, Zhaobin Zhang, (unknown), (unknown), Oltea Sampetrean, Jeffrey J. Olson, G. Yancey Gillespie, Hideyuki Saya, Christopher D. Willey, Erwin G. Van Meir	63
5	Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines 2021 ·Cancers ·(unknown), (unknown), Raoud Marayati, (unknown), (unknown), Jerry E. Stewart, Trung Vu, Juliet Easlick, Elizabeth Mroczek‐Musulman, David K. Crossman, Joshua C. Anderson, Christopher D. Willey, Pran K. Datta, Elizabeth A. Beierle	8
6	Surface guided imaging during stereotactic radiosurgery with automated delivery 2020 ·Journal of Applied Clinical Medical Physics ·Elizabeth Covington, Dennis N. Stanley, John B. Fiveash, Evan Thomas, Samuel Marcrom, (unknown), Christopher D. Willey, Kristen Riley, Richard A. Popple	18
7	Spleen Tyrosine Kinase–Mediated Autophagy Is Required for Epithelial–Mesenchymal Plasticity and Metastasis in Breast Cancer 2019 ·Cancer Research ·Aparna Shinde, Shana D. Hardy, Dong Wook Kim, Saeed Salehin Akhand, Mohit Kumar Jolly, Wen‐Hung Wang, Joshua C. Anderson, Ryan B. Khodadadi, Wells S. Brown, Jason T. George, Sheng Liu, Jun Wan, Herbert Levine, Christopher D. Willey, Casey J. Krusemark, Robert L. Geahlen, Michael K. Wendt	97
8	Electromagnetic Transponder Based Tracking and Gating in the Radiotherapeutic Treatment of Thoracic Malignancies 2019 ·Practical Radiation Oncology ·Drexell H. Boggs, Richard A. Popple, Andrew M. McDonald, (unknown), Christopher D. Willey, Sharon A. Spencer, Sui Shen, M.C. Dobelbower	8
9	Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer 2019 ·NOT FOUND REPOSITORY (Indian Institute of Science Bangalore) ·Aparna Shinde, Shana D. Hardy, Dong Wook Kim, Saeed Salehin Akhand, Mohit Kumar Jolly, Wen‐Hung Wang, Joshua C. Anderson, Ryan B. Khodadadi, Wells S. Brown, Jason T. George, Sheng Liu, Jun Wan, Herbert Levine, Christopher D. Willey, Casey J. Krusemark, Robert L. Geahlen, Michael K. Wendt	1
10	The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor 2019 ·Oncotarget ·Jamie M. Aye, (unknown), (unknown), (unknown), Jerry E. Stewart, Joshua C. Anderson, (unknown), (unknown), (unknown), (unknown), (unknown), Raoud Marayati, Elizabeth Mroczek‐Musulman, Christopher D. Willey, Karina J. Yoon, Kimberly Whelan, Elizabeth A. Beierle	6
11	Differential escape mechanisms in cetuximab-resistant head and neck cancer cells 2019 ·Biochemical and Biophysical Research Communications ·Christopher D. Willey, Joshua C. Anderson, Hoa Q. Trummell, (unknown), Rik de Wijn, Eddy S. Yang, Markus Bredel, Nanda K. Thudi, James A. Bonner	15
12	Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome 2016 ·SpringerPlus ·Christopher Straka, (unknown), Feng‐Ming Kong, Christopher D. Willey, Joseph Kaminski, (unknown)	81
13	Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing 2016 ·Journal of Visualized Experiments ·(unknown), (unknown), Joshua C. Anderson, Catherine P. Langford, (unknown), G. Yancey Gillespie, Raj Singh, Christopher D. Willey	17
14	Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition 2015 ·BMC Cancer ·James A. Bonner, Hoa Q. Trummell, (unknown), Christopher D. Willey, Markus Bredel, Eddy S. Yang	15
15	Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity 2014 ·International Journal of Oncology ·(unknown), (unknown), Joshua C. Anderson, Hoa Q. Trummell, Patricia H. Hicks, Alice N. Weaver, Eddy S. Yang, Robert A. Oster, Jessy S. Deshane, Chad Steele, Gene P. Siegal, James A. Bonner, Christopher D. Willey	15
16	MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma 2012 ·Clinical Cancer Research ·(unknown), Joshua C. Anderson, Christine W. Duarte, Tapan Mehta, Somaira Nowsheen, Patricia H. Hicks, Alexander C. Whitley, (unknown), Raymond O. McCubrey, (unknown), (unknown), James A. Bonner, G. Yancey Gillespie, Eddy S. Yang, Christopher D. Willey	47
17	Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor 2009 ·Molecular Cancer Therapeutics ·Luigi Moretti, Kwang Woon Kim, Dae Kwang Jung, Christopher D. Willey, Jiahong Lu	43
18	Enzastaurin (LY317615), a Protein Kinase C Beta Selective Inhibitor, Enhances Antiangiogenic Effect of Radiation 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Christopher D. Willey, Dakai Xiao, Tianxiang Tu, Kwang Woon Kim, Luigi Moretti, Kenneth J. Niermann, (unknown), C. Chad Quarles, Bo Lü	18
19	Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases 2006 ·Journal of Molecular and Cellular Cardiology ·Sundaravadivel Balasubramanian, (unknown), Hirokazu Shiraishi, (unknown), Kentaro Yamane, Christopher D. Willey, George Cooper, (unknown), Dhandapani Kuppuswamy	44
20	Integrin Activation and Focal Complex Formation in Cardiac Hypertrophy 2000 ·Journal of Biological Chemistry ·Martin Laser, Christopher D. Willey, (unknown), George Cooper, Donald R. Menick, Michael R. Zile, Dhandapani Kuppuswamy	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact